Doctor Care Anywhere Group PLC (ASX: DOC) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Doctor Care Anywhere Group PLC Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $97.96 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 329.66 million
Earnings per share -0.180
Dividend per share N/A
Year To Date Return -57.08%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Doctor Care Anywhere Group PLC (ASX: DOC)
Latest News

DOC ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Doctor Care Anywhere Group PLC

Doctor Care Anywhere Group PLC is engaged in providing digital healthcare services. The company utilizes its relationship with health insurers, healthcare providers, and corporate customers to connect with patients and deliver a range of telehealth services.

DOC Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
03 Dec 2021 $0.52 $0.00 0.00% 252,971 $0.52 $0.53 $0.50
02 Dec 2021 $0.52 $-0.01 -1.92% 87,290 $0.52 $0.52 $0.50
01 Dec 2021 $0.52 $-0.02 -3.74% 82,027 $0.53 $0.53 $0.52
30 Nov 2021 $0.54 $0.01 1.89% 85,353 $0.54 $0.54 $0.52
29 Nov 2021 $0.53 $-0.01 -1.85% 218,080 $0.53 $0.54 $0.52
26 Nov 2021 $0.54 $-0.01 -1.82% 187,154 $0.56 $0.57 $0.53
25 Nov 2021 $0.55 $0.03 5.71% 185,012 $0.53 $0.56 $0.53
24 Nov 2021 $0.53 $0.03 6.00% 142,290 $0.51 $0.54 $0.50
23 Nov 2021 $0.50 $-0.03 -5.66% 535,544 $0.53 $0.53 $0.49
22 Nov 2021 $0.53 $-0.01 -1.85% 138,025 $0.55 $0.55 $0.53
19 Nov 2021 $0.54 $-0.01 -1.83% 366,913 $0.55 $0.55 $0.52
18 Nov 2021 $0.55 $0.01 1.85% 72,618 $0.55 $0.56 $0.55
17 Nov 2021 $0.54 $-0.02 -3.57% 256,224 $0.56 $0.57 $0.54
16 Nov 2021 $0.56 $-0.02 -3.42% 337,228 $0.59 $0.59 $0.54
15 Nov 2021 $0.59 $0.00 0.00% 129,937 $0.60 $0.60 $0.59
12 Nov 2021 $0.59 $-0.02 -3.33% 365,458 $0.61 $0.61 $0.58
11 Nov 2021 $0.60 $-0.01 -1.64% 96,974 $0.61 $0.61 $0.60
10 Nov 2021 $0.61 $-0.01 -1.63% 108,822 $0.61 $0.62 $0.61
09 Nov 2021 $0.62 $-0.01 -1.61% 226,660 $0.62 $0.63 $0.61
08 Nov 2021 $0.62 $0.01 1.63% 162,490 $0.62 $0.62 $0.61
05 Nov 2021 $0.62 $-0.03 -4.69% 236,438 $0.64 $0.65 $0.61
04 Nov 2021 $0.64 $0.01 1.59% 278,722 $0.63 $0.66 $0.63

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Richard John Dammery Non-Executive Director Sep 2020
Mr Dammery has board and governance experience, having served on and advised a range of boards over the past 25 years. Before commencing his non-executive career, Richard held senior leadership roles in a range of major Australian and New Zealand companies, including Woolworths Group where he was the Chief Legal Officer and Company Secretary, responsible for legal and regulatory advice, group governance and group compliance. Prior to this, Richard held a number of commercial general management roles, principally in the telecommunications and technology sectors. From 2008-2014 Richard was a partner of leading law firm, Minter Ellison, specialising in corporate advice and mergers and acquisitions. Richard currently serves on the boards of Nexus Hospitals Group, Aussie Broadband Limited and Creative Partnerships Australia. He is an Adjunct Professor (Practice) and Industry Fellow at Monash Business School. He is chairman of Risk Management Committee.
Ms Vanessa Miscamble Wallace Non-Executive Director Sep 2020
Ms Wallace is an experienced board director, strategy management consultant, investor and founder in innovative, early-stage and digital companies. This includes being Chair of AMP Capital Ltd (from 2016 to 2018) and Drop Bio Pty Ltd (from 2018 to present) and Managing Director of Miscamble Forrest Pty Ltd as well as being a non-executive director of Global Board of Booz & Company (2006-2010), Wesfarmers Ltd (2010-present) and SEEK Ltd (2017-present). Vanessa spent more than 25 years at Booz & Company as a Senior Partner and Executive Chairman in Japan, and a Director of several Asian entities of the business. She led the Financial Services Practice in global markets and the strategy practice in Australia. She has extensive experience in post-merger integration, risk management and supporting leadership teams with their strategies and operational delivery. In the health care sector, Vanessa spent years as a consultant supporting providers across Australia and has been an investor in disruptive, innovative health care business for the last 15 years. More recently, Vanessa has worked with global life and health insurers and early stage ventures building data analytic capabilities and integrating biotechnology and data to define new health care solutions. She is also currently undertaking the MIT Engineering School's Professional Certificate Program in Machine Learning & Artificial Intelligence. Vanessa is a Member of the UNSW Business School Advisory Council and a Member of the Australian Chamber Orchestra Chairman's Council. She is member of Risk Management Committee.
Mr Jonathan Baines Executive ChairmanExecutive Director Nov 2018
Mr Baines has board and governance experience in the UK, having previously served on and advised both public and private company boards. Jonathan has also previously advised the UK Financial Services Authority (forerunner to the Prudential Regulatory Authority) on matters related to governance and succession planning. Prior to this, Jonathan spent 12 years in the British Army before joining and subsequently managing the UK Treasury division of Brown Shipley PLC. He spent 26 years in the executive search industry, starting his own company in 1986 which he sold to Whitehead Mann PLC, where he led the financial services practice before becoming Chairman in 2005. From 2005 to 2014, he served as Chairman of Korn Ferry Inc in Europe, the Middle East and Africa (EMEA) where he was involved in Chair and CEO succession planning at a number of the largest global financial services companies, including one of the leading banks in Australia. Since leaving the search industry in 2014, Jonathan has continued to advise and work closely with Citigroup in EMEA on client activities, as a Senior Adviser at Tulchan Communications, and as Chairman of Candy Kittens, a private and rapidly growing confectionery business.
Ms Romana Abdin Non-Executive Director Sep 2020
Ms Abdin has led the restructuring and investment in digital capability to meet the demands of today's customers, employers and healthcare practitioners, developing new propositions, establishing new relationships, developing people capabilities and a leadership team which has shifted the culture from risk averse and analogue to more customer-centric, agile and engaged. Romana has a industry profile in the UK and has gained extensive commercial, board, governance and regulatory experience in previous roles at Simplyhealth Group, Lloyds Banking Group and Bradford & Bingley Building Society. Romana started her career as a Barrister in London specialising in corporate and commercial law and went on to hold several corporate affairs and legal roles, principally in the financial services and entertainment sectors. She is member of Risk Management Committee.
Mr Simon Calver Non-Executive Director Oct 2020
Mr Calver has experience leading fast-growing technology businesses. Simon is an experienced non-executive board director, investor in technology, chief executive and entrepreneur. Simon has won recognition for his work at LoveFilm and with Entrepreneurs through the UK. As well as EY's Entrepreneur of the Year, he won the Sunday Times Buyout Track for PE backed businesses and the Confederation British Industries (CBI) Growth Company of the Year. Previous roles include being Chairman of technology start-up companies Moo Print Limited and Chemist Direct Limited, recipe box subscription company Gousto Ltd, Firefly Learning Ltd and UK Business Angels Association, Non-Executive Director of Global App Testing and Datalex PLC and CEO of Mothercare PLC and LoveFilm International until its sale to Amazon in 2011. In 2015, Simon set up BGF Ventures, a 200 million venture fund and substantial shareholder of Doctor Care Anywhere. Prior to this, Simon worked for large blue-chip companies such as Unilever, Pepsi and Dell. Simon speaks regularly on corporate change, leadership and disruptive business models.
Mr David Ravech Non-Executive Director Apr 2015
Mr Ravech has led and invested in disruptive technology companies for more than 20 years. Prior to his involvement with Doctor Care Anywhere, David was the founder and CEO of Overland Health (now part of Slater and Gordon Solutions), a technologydriven provider of rehabilitation services. He also founded and was later Co-CEO of Global Freight Exchange which provided the world's leading airlines and freight forwarders with the first online price and availability comparison engine and transaction system for airfreight (with the company being sold in 2007 to Descartes (Nasdaq: DSGX), a provider of cloudbased logistics and supply chain management solutions). He then spent six years as a strategy management consultant at McKinsey, based in the Melbourne and London offices. He has worked in Australia, the UK, Japan, Israel and several European countries, primarily serving clients in the retail, brewing, telecoms and banking sectors with a focus on mergers and acquisitions, competition law approvals and pricing strategy.
Dr Bayju Thakar Chief Executive OfficerExecutive Director Feb 2014
Dr Thakar has been responsible for leading the Company's growth from inception through to a vertically integrated digital health provider, serving some of the largest blue-chip health insurers and hospital groups in the world.
Mr Daniel (Dan) Curran Chief Financial OfficerCompany Secretary Jan 2021
Daniel (Dan) Curran Chief Financial OfficerCompany Secretary
Kate Bunyan Chief Medical Officer
Ben Kent Chief Operating and Financial Officer

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Carani Holdings Limited 44,264,604 13.90%
National Nominees Limited 32,592,870 10.23%
Vijay Patel 26,094,880 8.19%
HSBC Custody Nominees (Australia) Limited 20,055,115 6.30%
BGF Nominees Limited <BGF Investments LP A/C> 18,042,248 5.66%
UBS Nominees Pty Ltd 17,687,081 5.55%
Citicorp Nominees Pty Limited 16,255,023 5.10%
Bayju Ashvin Thakar 12,668,969 3.98%
Patagorang Pty Limited 11,245,121 3.53%
CS Third Nominees Pty Limited <HSBC Cust Nom Au Ltd 13 A/C> 9,091,199 2.85%
Bhikhu Patel 8,698,178 2.73%
Hadston 1 LLP 8,587,773 2.70%
Morgan Stanley Australia Securities (Nominee) Pty Limited <No 1 Account> 7,200,000 2.26%
Tiga Trading Pty Ltd 6,247,560 1.96%
Carjay Investments Pty Ltd 4,881,750 1.53%
Xilan Capital Limited 3,949,773 1.24%
BGF Nominees Limited <BGF Ventures LP A/C> 3,742,855 1.17%
BNP Paribas Noms Pty Ltd <Drp> 3,265,218 1.03%
HSBC Custody Nominees (Australia) Limited A/C 2 3,075,598 0.97%
Barnett Waddingham Trustees (1996) Limited <Anthony Banks Ltd P/P A/C> 2,406,855 0.76%
Barnett Waddingham Trustees (1996) Limited <HRMP Directors P/Sch A/C> 2,406,855 0.76%
Barnett Waddingham Trustees (1996) Limited <Mj Rutherford Ltd D/Pf A/C> 2,406,855 0.76%